| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 44.70▼ | 44.97▼ | 45.09▼ | 45.10▼ | 46.94▼ |
| MA10 | 44.90▼ | 45.17▼ | 45.46▼ | 46.66▼ | 44.66▼ |
| MA20 | 44.94▼ | 45.62▼ | 45.43▼ | 47.65▼ | 38.14▲ |
| MA50 | 45.14▼ | 45.14▼ | 45.64▼ | 44.32▲ | 32.04▲ |
| MA100 | 45.48▼ | 45.84▼ | 47.40▼ | 36.36▲ | 23.02▲ |
| MA200 | 45.59▼ | 47.48▼ | 46.61▼ | 28.60▲ | 17.10▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.047▼ | -0.136▼ | -0.080▼ | -0.733▼ | 0.408▲ |
| RSI | 24.658▼ | 37.177▼ | 38.997▼ | 44.222▼ | 60.407▲ |
| STOCH | 17.050▼ | 22.921 | 12.371▼ | 20.154 | 75.907 |
| WILL %R | -93.151▼ | -97.191▼ | -98.016▼ | -83.506▼ | -27.771 |
| CCI | -186.667▼ | -203.356▼ | -134.795▼ | -98.026 | 28.052 |
|
Tuesday, September 08, 2026 02:00 PM
Qure N.V. (NASDAQ:QURE) submitted a biologics license application, or BLA, to the U.S. Food and Drug Administration for accelerated approval of ifezuntirgene inilparvovec, formerly AMT-130, in ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/09/26 | 45.575 | 45.87 | 44.40 | 44.48 | 817,482 |
| 09/09/26 | 45.71 | 46.98 | 45.37 | 46.00 | 1,304,692 |
| 08/09/26 | 43.375 | 46.25 | 43.05 | 45.68 | 1,349,958 |
| 04/09/26 | 44.91 | 45.16 | 43.90 | 44.50 | 991,282 |
| 03/09/26 | 45.50 | 46.03 | 44.03 | 44.86 | 1,299,555 |
| 02/09/26 | 50.72 | 50.97 | 45.25 | 46.23 | 2,478,164 |
| 01/09/26 | 48.63 | 48.8475 | 47.29 | 47.86 | 748,788 |
| 31/08/26 | 48.23 | 48.86 | 47.61 | 48.68 | 1,643,038 |
| 28/08/26 | 49.19 | 49.51 | 48.29 | 48.72 | 843,554 |
| 27/08/26 | 50.83 | 51.03 | 49.51 | 49.56 | 778,347 |
|
|
||||
|
|
||||
|
|